[HTML][HTML] Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?

KR Thomsen, B Thylstrup, EA Kenyon, R Lees… - Neuroscience & …, 2022 - Elsevier
Cannabis use peaks during adolescence and emerging adulthood, and cannabis use
disorder (CUD) is associated with a wide range of adverse outcomes. This is particularly …

A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment

LC Bidwell, HC Karoly, MO Torres, A Master… - …, 2022 - Springer
Rationale Published studies examining the effects of cannabis have largely utilized forms of
cannabis that are not representative of the legal market products currently available …

Translational models of cannabinoid vapor exposure in laboratory animals

CF Moore, JW Stiltner, CM Davis… - Behavioural …, 2022 - journals.lww.com
Cannabis is one of the most frequently used psychoactive substances in the world. The most
common route of administration for cannabis and cannabinoid constituents such as Δ-9 …

Effects of daily Δ9-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman …

SL Withey, BD Kangas, S Charles, AB Gumbert… - Drug and alcohol …, 2021 - Elsevier
Background Daily use of marijuana is rising in adolescents, along with consumption of high
potency marijuana products (high% Δ-9-tetrahydrocannabinol or THC). These dual, related …

[HTML][HTML] Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder

R Lees, LA Hines, C Hindocha, G Baio… - …, 2023 - Springer
Rationale Chronic cannabis use is associated with impaired cognitive function. Evidence
indicates cannabidiol (CBD) might be beneficial for treating cannabis use disorder. CBD …

Nationale drug monitor

MW Van Laar, AAN Cruts, MMJ van Ooyen-Houben… - 2013 - repository.wodc.nl
De Nationale Drug Monitor (NDM) geeft sinds 1999 jaarlijks een cijfermatig overzicht van
wat bekend is over het gebruik van drugs en problemen rond drugs in Nederland. 1 De …

Thoughtfully integrating cannabis products into chronic pain treatment

KF Boehnke, CL Wu, DJ Clauw - Anesthesia & Analgesia, 2024 - journals.lww.com
Cannabis products (CPs) and cannabis-based medicines (CBMs) are becoming
increasingly available and are commonly used for pain management. The growing societal …

A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders

M Athanassiou, A Dumais, G Gnanhoue… - Expert review of …, 2021 - Taylor & Francis
Introduction: Research has established a link between cannabis use and adverse psychotic
outcomes in psychosis patients. However, we have yet to determine if this relationship is …

Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles

EV Fedorova, CF Wong, J Ataiants, E Iverson… - Drug and alcohol …, 2021 - Elsevier
Introduction Cannabidiol (CBD) is purportedly a promising therapeutic agent to provide relief
for a variety of medical conditions with mild or no psychoactive effects. However, little is …

[HTML][HTML] Adverse effects of heavy cannabis use: even plants can harm the brain

L Sideli, G Trotta, E Spinazzola, C La Cascia, M Di Forti - Pain, 2021 - journals.lww.com
The spread of laws legalising cannabis for medicinal or recreational use has been
accompanied by more relaxed attitudes towards cannabis. Data from the United States show …